PUBLIC CONTRACT · 2017
BEAD20170204 - Pertuzumab 420 mg/14 ml sol inj fr 14 ml IV
- Contract value
- €38,663.10
- Signed on
- 14 November 2017
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 3946121PUBLISHED SUBJECT
BEAD20170204 - PERTUZUMAB 420 MG/14 ML SOL INJ FR 14 ML IV
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Região Autónoma da Madeira, Funchal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Roche Farmacêutica Quimica, Lda. · Tax ID 500233810
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €38,663.10
- Procedure base price
- €38,663.10
- Total effective price
- €38,663.10
- Publication date
- 28 November 2017
- Award date
- 8 November 2017
- Signing date
- 14 November 2017
- Performance period
- 47 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Not stated
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos e DLR no 34/2008/M, de 14.08
- Framework agreement
- CP2015/6 MEDICAMENTOS FORO ONCOLOGICO ABERTO PELA SPMS P259-AC-2016-89
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 3041646
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.